PTPRG and metabolic dysfunction-associated steatotic liver disease: In humans, we found that hepatic PTPRG mRNA contents increase proportionally to the severity of non-alcoholic fatty liver disease (NAFLD); a condition associated with increased inflammation and insulin resistance22, 23.